Zevra Therapeutics (ZVRA) Treasury Shares (2014 - 2026)

Zevra Therapeutics' Treasury Shares history runs 6 years deep, the most recent figure standing at $11.0 million for Q1 2026.

• Quarterly Treasury Shares changed 0.0% year-over-year to $11.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.0 million (changed 0.0% YoY) and the FY2025 annual result came in at $11.0 million, changed 0.0% from the prior year.
• Treasury Shares was $11.0 million for Q1 2026 at Zevra Therapeutics, roughly flat from $11.0 million in the prior quarter.
• Across five years, Treasury Shares topped out at $1.8 million in Q4 2024 and bottomed at $320161.0 in Q4 2021.
• A 5-year average of $1.2 million and a median of $909953.0 in 2022 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2023 — Treasury Shares fell 27.02% — and 2024, when it jumped 218.62%.
• Zevra Therapeutics' Treasury Shares stood at $4.7 million in 2022, then decreased by 27.02% to $3.4 million in 2023, then soared by 218.62% to $11.0 million in 2024, then changed by 0.0% to $11.0 million in 2025, then changed by 0.0% to $11.0 million in 2026.
• Business Quant data shows ZVRA's Treasury Shares at $11.0 million in Q1 2026, $11.0 million in Q4 2025, and $11.0 million in Q3 2025.